Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis

Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis

Objectives Evaluation of remdesivir, an RNA polymerase inhibitor, for effectiveness in adults with COVID-19.Data sources Electronic search for eligible articles of PubMed, Cochrane Central and clinicaltrials.gov was performed on 20 September 2020.Participants and study eligibility criteria Only rand...

Full description

Bibliographic Details
Main Authors:	Daisy Khera, Ankita Chugh, Vinay Kumar Chugh, Pushpinder Singh Khera, Surjit Singh
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-06-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/11/6/e048416.full

Similar Items

BCG vaccination impact on mortality and recovery rates in COVID-19: A meta-analysis
by: Surjit Singh, et al.
Published: (2021-08-01)

Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19
by: Niti Mittal, et al.
Published: (2021-01-01)

Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis
by: Mohammad Tasavon Gholamhoseini, et al.
Published: (2021-05-01)

A systematic review and meta-analysis of the efficacy and safety of remdesivir in COVID-19 patients
by: Sumanta Saha, et al.
Published: (2021-03-01)

Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
by: Alejandro Piscoya, et al.
Published: (2020-01-01)

Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
by: Piscoya, Alejandro, et al.
Published: (2021)

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
by: Goran Kokic, et al.
Published: (2021-01-01)

Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis
by: Vikas Bansal, et al.
Published: (2021-01-01)

The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir
by: Yan Zhao, et al.
Published: (2021-08-01)

Remdesivir, compuesto con potencial terapéutico contra SARS-CoV-2
by: Anthony Paul Bautista-Pariona, et al.
Published: (2021-02-01)

Hybrid physiologically‐based pharmacokinetic model for remdesivir: Application to SARS‐CoV‐2
by: James M. Gallo
Published: (2021-05-01)

Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials
by: Desye Gebrie, et al.
Published: (2020-06-01)

Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020-09-01)

The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review
by: Amirhossein Roshanshad, et al.
Published: (2020-10-01)

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
by: Vanessa Monteil, et al.
Published: (2021-01-01)

A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
by: Alexander Simonis, et al.
Published: (2021-01-01)

Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
by: Hsing-Yu Hsu, et al.
Published: (2021-08-01)

Safety and Efficacy of Remdesivir in the Treatment of Covid-19: A Rapid Review of Available Evidence
by: Zahra Gharibnaseri, et al.
Published: (2020-10-01)

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside
by: Sijia Tao, et al.
Published: (2021-01-01)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
by: Ahmad F. Eweas, et al.
Published: (2021-01-01)

Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir
by: Supasek Kongsomros, et al.
Published: (2021-09-01)

The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis
by: Chenchula Santenna, et al.
Published: (2021-09-01)

Addendum to Systematic Review of Remdesivir for the Treatment of COVID-19
by: Arif Musa, et al.
Published: (2020-07-01)

An unusual variation of radicular dentin dysplasia: A rare case report with review of literature
by: Arun K Patnana, et al.
Published: (2020-01-01)

Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
by: Katya Uzunova, et al.
Published: (2020-11-01)

Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir
by: Daniel Camprubí, et al.
Published: (2021-03-01)

Safety profile of the antiviral drug remdesivir: An update
by: Qianqian Fan, et al.
Published: (2020-10-01)

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
by: Timothy P. Sheahan, et al.
Published: (2020-01-01)

Remdesivir for the treatment of COVID-19: a living systematic review
by: Francisca Verdugo-Paiva, et al.
Published: (2020-12-01)

Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature
by: Arif Musa, et al.
Published: (2020-07-01)

A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants
by: Philippe Colson, et al.
Published: (2021-07-01)

Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia
by: Emanuele Palomba, et al.
Published: (2021-09-01)

Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
by: Rameez Hassan Pirzada, et al.
Published: (2021-04-01)

Early orthopedic correction of skeletal Class III malocclusion using combined reverse twin block and face mask therapy
by: Vinay Kumar Chugh, et al.
Published: (2015-01-01)

CT Quadrate Lobe Hot Spot Sign
by: Binit Sureka, et al.
Published: (2018-07-01)

High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance
by: Aditya K. Padhi, et al.
Published: (2021-01-01)

Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2
by: Yejin Jang, et al.
Published: (2021-02-01)

Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects
by: Rita Humeniuk, et al.
Published: (2020-09-01)

Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports
by: Alaaeldin Abdelmajid, et al.
Published: (2021-01-01)

Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
by: Yi-Hao Chan, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_ssrthqnb113d94fh6htff9pqi9